Stock Analysis, Dividends, Split History

WLKP / Westlake Chemical Partners LP financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)852.68
Enterprise Value ($M)822.58
Book Value ($M)964.47
Book Value / Share29.92
Price / Book0.88
NCAV ($M)-284.95
NCAV / Share-8.84
Price / NCAV-2.94
Share Statistics
Common Shares Outstanding 32,237,266
Common Shares Outstanding2 0
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.35
Return on Assets (ROA)0.23
Return on Equity (ROE)0.38
Balance Sheet (mrq) ($M)
Quick Ratio4.97
Current Ratio5.10
Income Statement (mra) ($M)
Revenue From Related Parties973,081,000.00
Other Sales Revenue Net199,900,000.00
Sales Revenue Net1,172,981,000.00
Operating Income374.41
Net Income353.06
Cash Flow Statement (mra) ($M)
Cash From Operations537.36
Cash from Investing-203.23
Cash from Financing-203.23
Identifiers and Descriptors
Central Index Key (CIK)1604665
Related CUSIPS
960417903 960417953

Split History

Stock splits are used by Westlake Chemical Partners LP to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

New Strong Sell Stocks for August 13th

2018-08-13 zacks
ZTO Express (Cayman) Inc. (ZTO - Free Report) is a provider of express delivery and other value-added logistics services. The Zacks Consensus Estimate for its current year earnings has been revised 6.9% downward over the last 30 days. (1-1)

Westlake Chemical (WLK) Q2 2018 Results - Earnings Call Transcript

2018-08-02 seekingalpha
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Westlake Chemical Corporation's Second Quarter 2018 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode. After the speakers' remarks, you will be invited to participate in a question-and-answer session. As a reminder, ladies and gentlemen, this conference is being recorded today, August 2, 2018. (2-0)

Westlake Chemical Partners (WLKP) Resetting Of The IDR Tiers To Enhance The Long-Term Value Of The Partnership Benefitting Both Partners And Westlake

2018-07-31 seekingalpha
The following slide deck was published by Westlake Chemical Partners LP in conjunction with this event.

John And Jane: May Dividend Income Tracker - Taxable Account

2018-06-11 seekingalpha
This is the seventh month I have officially tracked the taxable account's dividend income, and it was slightly below expectations with a total of $1,642.46 of dividends received. (316-0)

Westlake Chemical Partners' (WLKP) CEO Albert Chao on Q1 2018 Results - Earnings Call Transcript

2018-05-05 seekingalpha
Westlake Chemical Partners LP (NYSE:WLKP) Q1 2018 Earnings Conference Call May 3, 2018 12:00 PM ET (0-1)

CUSIP: 960417103